214 related articles for article (PubMed ID: 25475881)
1. The impact of registration of clinical trials units: the UK experience.
McFadden E; Bashir S; Canham S; Darbyshire J; Davidson P; Day S; Emery S; Pater J; Rudkin S; Stead M; Brown J
Clin Trials; 2015 Apr; 12(2):166-73. PubMed ID: 25475881
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
3. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
4. Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials.
Cui Y; Galvin JM; Parker W; Breen S; Yin FF; Cai J; Papiez LS; Li XA; Bednarz G; Chen W; Xiao Y
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):271-7. PubMed ID: 22541964
[TBL] [Abstract][Full Text] [Related]
5. [Analysis and discussion on current condition of acupuncture clinical research registration].
Xu Y; Chen B; Guo Y
Zhongguo Zhen Jiu; 2015 Jun; 35(6):605-7. PubMed ID: 26480568
[TBL] [Abstract][Full Text] [Related]
6. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
7. The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK.
Hearn J; Sullivan R
Eur J Cancer; 2007 Jan; 43(1):8-13. PubMed ID: 17118647
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
Zon R; Meropol NJ; Catalano RB; Schilsky RL
J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
[TBL] [Abstract][Full Text] [Related]
9. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
10. Clinical research, national studies and grant applications: United Kingdom National Multidisciplinary Guidelines.
Stafford N
J Laryngol Otol; 2016 May; 130(S2):S216-S217. PubMed ID: 27841137
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the introduction of Clinical Trial Officer roles into the cancer clinical trial setting in the UK.
Cox K; Avis M; Wilson E; Elkan R
Eur J Cancer Care (Engl); 2005 Dec; 14(5):448-56. PubMed ID: 16274467
[TBL] [Abstract][Full Text] [Related]
12. Getting our house in order: an audit of the registration and publication of clinical trials supported by the National Institute for Health Research Oxford Biomedical Research Centre and the Musculoskeletal Biomedical Research Unit.
Tompson AC; Petit-Zeman S; Goldacre B; Heneghan CJ
BMJ Open; 2016 Mar; 6(3):e009285. PubMed ID: 26936902
[TBL] [Abstract][Full Text] [Related]
13. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
14. Experiences of establishing an academic early phase clinical trials unit.
Brown SR; Sherratt D; Booth G; Brown J; Collinson F; Gregory W; Flanagan L
Clin Trials; 2017 Aug; 14(4):349-356. PubMed ID: 28532202
[TBL] [Abstract][Full Text] [Related]
15. Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service.
Debruyne PR; Johnson PJ; Pottel L; Daniels S; Greer R; Hodgkinson E; Kelly S; Lycke M; Samol J; Mason J; Kimber D; Loucaides E; Parmar MK; Harvey S;
Clin Trials; 2015 Jun; 12(3):257-64. PubMed ID: 25652529
[TBL] [Abstract][Full Text] [Related]
16. TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials.
Boyce M; Walther M; Nentwich H; Kirk J; Smith S; Warrington S
Eur J Clin Pharmacol; 2012 Jul; 68(7):1019-24. PubMed ID: 22349161
[TBL] [Abstract][Full Text] [Related]
17. A third trial oversight committee: Functions, benefits and issues.
Lane JA; Gamble C; Cragg WJ; Tembo D; Sydes MR
Clin Trials; 2020 Feb; 17(1):106-112. PubMed ID: 31665920
[TBL] [Abstract][Full Text] [Related]
18. United Kingdom health research analyses and the benefits of shared data.
Carter JG; Sherbon BJ; Viney IS
Health Res Policy Syst; 2016 Jun; 14(1):48. PubMed ID: 27342284
[TBL] [Abstract][Full Text] [Related]
19. Governance of clinical research.
Camilleri M; Tremaine WJ
Am J Gastroenterol; 2012 Mar; 107(3):336-8. PubMed ID: 22388015
[TBL] [Abstract][Full Text] [Related]
20. Implementing a centralised pharmacovigilance service in a non-commercial setting in the United Kingdom.
Dinnett EM; Kean S; Tolmie EP; Ronald ES; Gaw A
Trials; 2013 Jun; 14():171. PubMed ID: 23758677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
